Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (131-140 of 203) with videos related to

Pageof 21
Sort By:
European Journal of Clinical Pharmacology|September 11, 2001
Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patientsP L Lohmann, M L Rao, M Ludwig, et al.
Pharmacogenetics and Genomics|July 26, 2005
Three haplotypes associated with CYP2A6 phenotypes in CaucasiansMichael Haberl, Birgit Anwald, Kathrin Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2015
Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation PotentialGuillaume Margaillan, Michèle Rouleau, Kathrin Klein, et al.
Frontiers in Pharmacology|June 17, 2017
Effect of Genetic Variability in the <i>CYP4F2</i>, <i>CYP4F11</i>, and <i>CYP4F12</i> Genes on Liver mRNA Levels and Warfarin ResponseJ E Zhang, Kathrin Klein, Andrea L Jorgensen, et al.
Frontiers in Genetics|February 16, 2019
A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver CohortKathrin Klein, Roman Tremmel, Stefan Winter, et al.
Human Genetics|December 2, 2019
Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expressionRoman Tremmel, Kathrin Klein, Florian Battke, et al.
British Journal of Clinical Pharmacology|December 18, 2003
Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicityJanet K Coller, Niels Krebsfaenger, Kathrin Klein, et al.
Human Mutation|February 19, 2013
Novel CYP2B6 enzyme variants in a Rwandese population: functional characterization and assessment of in silico prediction toolsRobert Radloff, Alain Gras, Ulrich M Zanger, et al.
Molecular Pharmacology|January 9, 2013
Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα)Maria Thomas, Oliver Burk, Britta Klumpp, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugationMonika Bredschneider, Kathrin Klein, Thomas E Mürdter, et al.
Pageof 21

Showing results (131-140 of 203) with videos related to

Sort By:
Pageof 21
European Journal of Clinical Pharmacology|September 11, 2001
Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patientsP L Lohmann, M L Rao, M Ludwig, et al.
Pharmacogenetics and Genomics|July 26, 2005
Three haplotypes associated with CYP2A6 phenotypes in CaucasiansMichael Haberl, Birgit Anwald, Kathrin Klein, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2015
Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation PotentialGuillaume Margaillan, Michèle Rouleau, Kathrin Klein, et al.
Frontiers in Pharmacology|June 17, 2017
Effect of Genetic Variability in the <i>CYP4F2</i>, <i>CYP4F11</i>, and <i>CYP4F12</i> Genes on Liver mRNA Levels and Warfarin ResponseJ E Zhang, Kathrin Klein, Andrea L Jorgensen, et al.
Frontiers in Genetics|February 16, 2019
A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver CohortKathrin Klein, Roman Tremmel, Stefan Winter, et al.
Human Genetics|December 2, 2019
Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expressionRoman Tremmel, Kathrin Klein, Florian Battke, et al.
British Journal of Clinical Pharmacology|December 18, 2003
Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicityJanet K Coller, Niels Krebsfaenger, Kathrin Klein, et al.
Human Mutation|February 19, 2013
Novel CYP2B6 enzyme variants in a Rwandese population: functional characterization and assessment of in silico prediction toolsRobert Radloff, Alain Gras, Ulrich M Zanger, et al.
Molecular Pharmacology|January 9, 2013
Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα)Maria Thomas, Oliver Burk, Britta Klumpp, et al.
Clinical Pharmacology and Therapeutics|June 28, 2002
Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugationMonika Bredschneider, Kathrin Klein, Thomas E Mürdter, et al.
Pageof 21